Syapse logo — Syapse is a RWE company dedicated to extinguishing the fear...

Syapse

Syapse is a RWE company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care.

Founded 2008 United States San Francisco, United States 27 employees Acquired Total: $222.60M

General Information

Company Name Syapse
Founded Year 2008
Location United States San Francisco, United States
Founders / Decision Makers
Team member
Employees 27
Funding Stage Acquired
Business Model B2B, SaaS, Platform
Revenue Model Data Monetization, Subscription, Project Based
Social

BounceWatch is an independent company data service, not affiliated with Syapse. To contact Syapse, visit syapse.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Syapse compare?

A PDF of Syapse and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Syapse soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Syapse

Syapse, founded in 2008, is an innovative Real-World Evidence (RWE) company based in the United States. Focusing on transforming real-world evidence into actionable insights, Syapse aims to alleviate the burden of serious diseases by advancing real-world care.

The company emphasizes precise and impactful care by facilitating collaboration among healthcare organizations, thereby empowering them to deliver comprehensive patient insights. This approach is particularly meaningful for cancer care and extends benefits to other serious disease areas.

In a bid to further its mission, Syapse secured a $35.00M Venture Round investment on July 27, 2022. This round saw participation from notable investors including Social Capital, Safeguard Scientifics, Ally Bridge Group, Innovatus Capital Partners, Northpond Ventures, Revelation Partners, and Merck Global Health Innovation Fund. These strategic investors underline the confidence in Syapse’s potential to drive meaningful advancements in healthcare.

Business keywords: Real-World Evidence, Precision Medicine, Personalized Medicine, Healthcare Partnerships, Cancer Care, Patient Insights, Collaborative Healthcare, Clinical Decision Support, Bioinformatics, Genomics, Health IT, Big Data in Healthcare, Cloud Computing in Healthcare, Omics, Semantic Computing

Services & Products

N-Power Prospective External Controls
N-Power Community Trial Accelerator
Research Embedded into Routine Care
Human-in-the-loop AI Platform
Point-of-Care Technology Solutions

Target Customers

Community Oncologists Pharmaceutical Companies Clinical Operations Teams Cancer Patients in Community Care

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition Undisclosed 1
Medici Ventures
01 Jan 2025
Late VC $35.00M 7
Social Capital, Safeguard Scientifics +5
01 Jul 2022
Growth Equity VC $68.00M 2
Ally Bridge Group, Northpond Ventures
01 Feb 2021
Late VC $30.00M 7
Amgen Ventures, Social Capital +5
01 May 2020
Series E $20.00M -
01 Jan 2019
Series D $30.00M 8
Amgen Ventures, GE Ventures +6
01 Nov 2017
Series C $25.00M 4
Social Capital, Ascension Ventures +2
01 Jan 2016
Series B $10.00M 2
Social Capital, Safeguard Scientifics
01 Jul 2014
Series A $3.00M 1
Social Capital
01 Jan 2013
Angel $1.60M -
01 Jan 2011

Syapse Alternatives & Competitors

Syapse vs
Aster Insights
Aster Insights United States

Accelerating oncology medical product discovery and development through our scientific and clinical...

Private Equity
78 employees
Biotechnology, Health Care
Syapse vs
Pierian
Pierian United States

Genomics in Practice

Venture round
55 employees
Biotechnology, Health Care
Syapse vs
Trapelo
Trapelo United States

How can we resolve the complexities of using precision medicine for cancer care? Trapelo knows.

Venture round
12 employees
Health Care, IT
Also compare with: Syapse vs BC Platforms BC Platforms

FAQ About Syapse

Syapse is a RWE company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care.
Syapse was founded in 2008.
Syapse is headquartered in San Francisco, United States.
Syapse has a B2B, SaaS and Platform business model. Its revenue comes from Data Monetization, Subscription and Project Based.
Syapse has approximately 27 employees.
Syapse has completed 10 funding rounds, raising a total of $222.60M. The latest funding stage is Acquired.
Syapse offers: N-Power Prospective External Controls, N-Power Community Trial Accelerator, Research Embedded into Routine Care, Human-in-the-loop AI Platform, Point-of-Care Technology Solutions.
Top alternatives and competitors to Syapse include Aster Insights, Pierian, Trapelo, Embleema, Ophiomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Syapse and Aster Insights are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Syapse, https://bouncewatch.com/company/syapse, updated 4 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes